Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Tuberculosis

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Exploring How Peru Is Addressing Drug-Resistant TB

Discussing the recent reports of so-called “totally drug-resistant” tuberculosis (TDR-TB) in India, journalist John Donnelly in this GlobalPost “Global Voices” blog entry writes, “Overall, the world is treating drug-resistant TB extraordinarily poorly, and that creates more and more cases of resistant TB that aren’t being cured.” Donnelly describes his experience in Peru, where he and photographer Riccardo Venturi recently traveled at the invitation of the Japanese company Otsuka Pharmaceutical and “met with local scientists, doctors and patients to explore the scope of the struggle to fight drug-resistant TB” (1/19).

India’s Ministry Of Health Dismisses Claims Of ‘Totally Drug-Resistant’ TB

In a January 17 statement, India’s Ministry of Health and Family Welfare “dismissed reports that a form of incurable tuberculosis [TB] has arrived in the country,” saying “that a team of doctors sent by the ministry found that seven of the patients are responding to treatment” and the cases would be classified and managed as extremely drug-resistant TB (XDR-TB), Nature News Blog reports (Jayaraman, 1/19). “Earlier, doctors in Mumbai said 12 patients had a ‘totally drug resistant’ form of TB, and three had died,” according to BBC News. “A WHO official in India told the BBC that there is no recognized case of totally drug resistant TB anywhere in the world,” the news service writes (1/20).

Indian, WHO Officials To Meet To Discuss Managing Cases Of Highly Drug-Resistant TB

Health officials from India and the WHO are scheduled to meet in Mumbai on Tuesday to discuss how to manage the cases of at least 12 patients infected with a highly drug-resistant tuberculosis (TB) strain, Bloomberg reports (Narayan, 1/17). “The ‘totally drug-resistant’ tuberculosis (TDR-TB) reportedly emerging in India is actually an advanced stage of drug-resistant TB, which researchers called totally drug-resistant for lack of a better term,” IRIN notes (1/17).

Address Drug Resistant Pathogens As Part Of ‘Next Stage Of Global Health’

This post in the Foreign Policy Association blog discusses reports from earlier this month of “an emerging strain of ‘totally drug-resistant’ tuberculosis (TDR-TB)” in India, which the Indian government last week denied, “arguing that the 12 cases were in fact extensively drug resistant (XDR).” The blog states, “Whether or not it’s fair to use the TDR moniker, drug resistance is a serious, emerging issue that may very well define the next stage of global health,” concluding, “We are reaching a turning point, one at which some drug resistant pathogens are on the cusp of shifting from a handful of cases, an endemic, to a bigger, epidemic or even pandemic problem. Now is the time to initiate discussions on what the global community will do to stem drug resistance” (Robinson, 1/21).

U.S. Should Assume Leadership Role In Saving Global Fund

A funding shortfall led the Global Fund to Fight AIDS, Tuberculosis and Malaria to announce in November that “it won’t make any grants to fund programs for at least two years,” a Deseret News editorial notes and calls on the U.S. to take a leadership position in saving the fund. The editorial states, “Few worldwide initiatives have the success record of the Global Fund …, but those breakthroughs may not have much chance to save many lives,” and notes that the non-profit lobbying group “Results is calling for the Obama administration to assemble an emergency meeting of donor nations this spring to find ways to ensure that the fund and its programs are able to continue and to provide new medicines where they are needed most.”

Cooperation Needed To Fight TB

In this post in Global Health Frontline News’ “Notes From the Field” blog, Kevin Cain, chief of the tuberculosis (TB) branch for a research and public health collaboration between the Kenya Medical Research Institute (KEMRI) and the CDC in Kisumu, Kenya, reports on TB research underway as part of the collaboration. Cain highlights several current research initiatives in Kisumu and concludes, “The world cannot afford another phase of neglect. We know by partnering with governments as well as affected communities in innovative ways more progress can be made improving programs and the tools available for diagnosing, treating, and preventing TB, and lives will be saved” (1/20).

International Roadmap For TB Research Outlines Priorities

In this post in the PLoS “Speaking of Medicine” blog, guest blogger Christian Lienhardt, senior scientific adviser at the Stop TB Partnership and WHO, “discusses the International Roadmap for Tuberculosis (TB) Research, a framework outlining priority areas for investment in TB research.” He writes, “The tools available for TB control are old, lack effectiveness, and are not readily accessible in many settings,” adding, “Fortunately there is hope, thanks to notable progress in the development of new tools for TB control over the last decade,” such as “the recent introduction of Xpert MTB/RIF — a DNA-based molecular assay that can diagnose TB and the presence of rifampicin-resistance in 100 minutes” (1/26).

Addressing TB Prevention, Treatment Among Migrant Populations

In this post on USAID’s “IMPACTblog,” Christina Lau, USAID health officer for Central Asia, discusses tackling tuberculosis (TB) in migrant populations, writing, “Most migrants are unable to access the health care system because they are undocumented laborers, who lack proper identification documents required for health care treatment, and who fear deportation if their documentation status becomes known.” She notes, “USAID is working in coalition with government and international partners in order to improve access to TB services and treatment for this crucial population” (1/26).

Cases Of Totally Drug-Resistant TB Reported In India

“For the first time in India, 12 people have been detected with totally drug-resistant lung tuberculosis (TDR-TB), a condition in which patients do not respond to any TB medication” and for which the mortality rate is 100 percent, the Hindustan Times reports. “Doctors treating these patients say the absolute resistance is a result of the patients being prescribed wrong antibiotics,” the newspaper reports (1/7). “While Iran first reported TDR-TB cases three years ago, India seems to be only the second country to report this deadly form of the disease,” the Times of India notes (Iyer, 1/7).

Blog Interviews UCLA Professor About Highly Drug-Resistant TB

The Los Angeles Times’ “Booster Shots” blog features an interview with Otto Yang, a professor at the Geffen School of Medicine at UCLA, who speaks about drug-resistant tuberculosis (TB) and the implications of a highly drug-resistant strain found in India. Yang said, “Obviously [the drug-resistant TB] could be devastating if it spreads, because treatment options are so limited. So far it seems not to have been as contagious as other strains, possibly because the mutations required to make it drug-resistant also make it a little less virulent” (Brown, 1/18).